Cargando…

Lipidomic approach for stratification of acute myeloid leukemia patients

The pathogenesis and progression of many tumors, including hematologic malignancies is highly dependent on enhanced lipogenesis. De novo fatty-acid synthesis permits accelerated proliferation of tumor cells by providing membrane components but these may also alter physicochemical properties of lipid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefanko, Adam, Thiede, Christian, Ehninger, Gerhard, Simons, Kai, Grzybek, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313223/ https://www.ncbi.nlm.nih.gov/pubmed/28207743 http://dx.doi.org/10.1371/journal.pone.0168781

Ejemplares similares

Chimeric antigen receptor T-cell therapy in acute myeloid leukemia
por: Koedam, Jan, et al.
Publicado: (2022)

Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia
por: Wobus, Manja, et al.
Publicado: (2015)

Comprehensive and quantitative analysis of white and brown adipose tissue by shotgun lipidomics
por: Grzybek, Michal, et al.
Publicado: (2019)

Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
por: Ehninger, A, et al.
Publicado: (2014)

Unified classification and risk-stratification in Acute Myeloid Leukemia
por: Tazi, Yanis, et al.
Publicado: (2022)

A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia
por: Docking, T. Roderick, et al.
Publicado: (2021)

Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia
por: Pourrajab, Fatemeh, et al.
Publicado: (2020)

Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia
por: Alakel, Nael, et al.
Publicado: (2017)

Flexibility of a Eukaryotic Lipidome – Insights from Yeast Lipidomics
por: Klose, Christian, et al.
Publicado: (2012)

Mouse lipidomics reveals inherent flexibility of a mammalian lipidome
por: Surma, Michał A., et al.
Publicado: (2021)

Novel Translocation in Acute Myeloid Leukemia: Case Report and Review of Risk-Stratification and Induction Chemotherapy in Patients With Acute Myeloid Leukemia
por: Jeha, George M., et al.
Publicado: (2020)

The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features
por: Pabst, Thomas, et al.
Publicado: (2017)

Feasibility of Azacitidine Added to Standard Chemotherapy in Older Patients with Acute Myeloid Leukemia — A Randomised SAL Pilot Study
por: Krug, Utz, et al.
Publicado: (2012)

The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy
por: Rybka, Justyna, et al.
Publicado: (2014)

Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
por: Rausch, Christian, et al.
Publicado: (2023)

S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Bill, Marius, et al.
Publicado: (2023)

Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia
por: Tober, Romy, et al.
Publicado: (2022)

Pilot Study on Mass Spectrometry–Based Analysis of the Proteome of CD34(+)CD123(+) Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia
por: Schmidt, Johannes R., et al.
Publicado: (2018)

Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia
por: Wang, Bian-Hong, et al.
Publicado: (2015)

Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia
por: Jentzsch, Madlen, et al.
Publicado: (2019)

Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia
por: Wakita, Satoshi, et al.
Publicado: (2023)

Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
por: Herold, Tobias, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease stratification by liver lipidomics
por: Vvedenskaya, Olga, et al.
Publicado: (2021)

Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
por: Kayser, S, et al.
Publicado: (2016)

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia
por: Fleischmann, Maximilian, et al.
Publicado: (2022)

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
por: Eckardt, Jan-Niklas, et al.
Publicado: (2022)

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
por: Jahn, Nikolaus, et al.
Publicado: (2022)

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
por: Bataller, Alex, et al.
Publicado: (2022)

Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling
por: Wang, M, et al.
Publicado: (2017)

Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification
por: Kansal, Rina
Publicado: (2016)

Risk Stratification in Acute Myeloid Leukemia Using CXCR Gene Signatures: A Bioinformatics Analysis
por: Lu, Cong, et al.
Publicado: (2020)

Pan-cancer analysis revealing that PTPN2 is an indicator of risk stratification for acute myeloid leukemia
por: Wang, Xuanyu, et al.
Publicado: (2023)

Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors
por: Boscaro, Eleonora, et al.
Publicado: (2023)

Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT
por: Brissot, Eolia, et al.
Publicado: (2019)

Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns
por: Božić, Tanja, et al.
Publicado: (2021)

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
por: Eckardt, Jan-Niklas, et al.
Publicado: (2023)

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing
por: Wang, Bianhong, et al.
Publicado: (2016)

Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts
por: Aliperta, R, et al.
Publicado: (2015)

Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy
por: Kadia, Tapan Mahendra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_msum6r9q2ouq8va1lhk8s8f3u5